PEMT and metabolic dysfunction-associated steatotic liver disease: We report that treatment with fenofibrate prevented and partially reversed NAFLD in Pemt−/− mice, whereas treatment with ezetimibe did not lower hepatic lipid accumulation, inflammation, or fibrosis in these mice.